Rani Therapeutics Holdings, Inc.
RANI
$1.05
-$0.05-4.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -90.41% | 19.13% | 7.87% | 18.81% | -31.90% |
| Total Depreciation and Amortization | -16.59% | -7.08% | -4.38% | -5.64% | 2.70% |
| Total Amortization of Deferred Charges | -43.10% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 1,243.29% | 153.07% | 49.43% | -211.09% | 185.40% |
| Change in Net Operating Assets | 2,397.69% | -121.38% | 4,242.86% | 102.47% | -72.56% |
| Cash from Operations | 105.81% | 12.65% | 28.87% | 5.85% | -2.91% |
| Capital Expenditure | -- | 100.00% | 27.45% | -64.52% | 75.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -68.54% | 616.30% | 329.63% |
| Cash from Investing | -- | -100.00% | -68.66% | 623.09% | 437.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -152.59% | 0.00% | 0.00% | 0.00% | -200.00% |
| Issuance of Common Stock | 3,746.37% | -25.57% | 9,295.24% | -99.58% | -0.85% |
| Repurchase of Common Stock | -200.00% | 12.50% | 65.22% | -155.56% | 35.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,163.49% | -- | -- | -- | 44.40% |
| Cash from Financing | 4,545.19% | -636.70% | 105.04% | -166.40% | -27.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 333.43% | -5,882.86% | -98.35% | 1,332.82% | -117.30% |